1. Contractors
  2. Universitat St. Gallen

Universitat St. Gallen

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Universitat St. Gallen has 3 federal contracts of $100,000 or more active since October 2023, with $1.72M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
3 since FY2024$1,715,367 obligated, contracts of $100,000 or more
Running now
1 contract1 ended in the last 12 months
Biggest customer
Food and Drug Administration$1.72M on 3 contracts
UEI
LLK6D5M1UAF1Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2021$764,418
FY2025$515,770
FY2026$435,179

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Baa Contract- FY26C2DP2-Beyond Compliance: Integrating Quality Culture and Risk in Pharmaceutical Quality ManagementFood and Drug Administration · 75F40126C00070$435,179Sep 29, 2027in 10 monthsMD

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Food and Drug Administration3 contracts$1,715,367

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 2 contracts$1,280,188
Colleges, Universities, and Professional SchoolsNAICS 611310 · 1 contract$435,179

Where the work is

Place of workAmount
Maryland3 contracts$1,715,367

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Food and Drug Administration: see the list.

Get new notices like Universitat St. Gallen's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy